Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6900024

T cell receptor ligands and methods of using same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6881395

TIE-2 ligand-4

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6878736

Histamine H3 receptor ligands

The James Black Foundation Limited · Granted Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6878734

Gastrin and cholecystokinin receptor ligands(II)

The James Black Foundation Limited · Granted Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6861228

Modulating Robo: ligand interactions

The Regents of the University of California · Granted Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6855810

Ligands directed to the non-secretory component, non-stalk region of plgR and methods of u

The Regents of the University of California · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6852838

Tyrosine kinase receptors and ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6849610

Polynucleotide ligands as anti-viral agents

The Regents of the University of California · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846908

DCR-5 bone affecting ligand

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846914

Tie-2 ligand-3

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846817

Nicotine receptor ligands

Regents of the University of Minnesota · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6841568

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6835744

3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6831093

Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof

The Regents of the University of California · Granted Tue Dec 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6825008

Expressed ligand—vascular intercellular signalling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6825222

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6808877

Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibi

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6794373

Contraceptive methods using benzimidazolones

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6783763

Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof

Peptide Immune Ligands · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6759396

Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6756399

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6750026

Screening methods using ligands of the neutropeptide receptor HFGAN72

The Board of Regents of the University of Texas System · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6750226

Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

Almirall Prodesfarma S.A. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)